Recent research suggests that among adults age 65 and older, a high-dose influenza vaccine may be associated with a lower risk of developing Alzheimer dementia compared with the standard-dose flu vaccine. However, the evidence is still observational and does not prove causation.Main findings from the 2026 study published in American Academy of Neurology journal Neurology: • About 165,000 adults ≥65 years were studied. • Those receiving the high-dose flu vaccine had a significantly lower Alzheimer risk during about the first 2 years after vaccination compared with those receiving the standard-dose vaccine.  • The estimated reduction was roughly: • about 15–20% relative risk reduction in many summaries,  • while some reports described up to ~55% lower risk during certain follow-up intervals depending on the analysis model used.  • The benefit appeared stronger and longer-lasting in women.  • Researchers estimated approximately: • 1 Alzheimer case pre
0 views
Skip to first unread message
zlim...@gmail.com
May 20, 2026, 2:54:33 PMMay 20
to itb// IDNF
Recent research suggests that among adults age 65 and older, a high-dose influenza vaccine may be associated with a lower risk of developing Alzheimer dementia compared with the standard-dose flu vaccine. However, the evidence is still observational and does not prove causation.
Main findings from the 2026 study published in American Academy of Neurology journal Neurology:
• About 165,000 adults ≥65 years were studied.
• Those receiving the high-dose flu vaccine had a significantly lower Alzheimer risk during about the first 2 years after vaccination compared with those receiving the standard-dose vaccine. 
• The estimated reduction was roughly:
• about 15–20% relative risk reduction in many summaries, 
• while some reports described up to ~55% lower risk during certain follow-up intervals depending on the analysis model used. 
• The benefit appeared stronger and longer-lasting in women. 
• Researchers estimated approximately:
• 1 Alzheimer case prevented per ~185 people receiving the high-dose vaccine. 
Important limitations:
• This was not a randomized controlled trial.
• People choosing high-dose vaccines may also:
• have better healthcare access,
• healthier lifestyles,
• better preventive care habits.
• Alzheimer disease develops over many years, but follow-up was only about 3 years. 
Possible mechanisms proposed:
• Better prevention of influenza infection and systemic inflammation.
• Modulation of immune activity and neuroinflammation.
• Stronger immune stimulation from the higher antigen dose. 
For older adults, the current practical interpretation is:
• Getting any flu vaccine is beneficial and important.
• If age ≥65 and available, the high-dose vaccine may provide somewhat better protection, both against influenza complications and possibly dementia risk.
• But it is still too early to say the high-dose vaccine definitively prevents Alzheimer disease. 
Main findings from the 2026 study published in American Academy of Neurology journal Neurology:
• About 165,000 adults ≥65 years were studied.
• Those receiving the high-dose flu vaccine had a significantly lower Alzheimer risk during about the first 2 years after vaccination compared with those receiving the standard-dose vaccine. 
• The estimated reduction was roughly:
• about 15–20% relative risk reduction in many summaries, 
• while some reports described up to ~55% lower risk during certain follow-up intervals depending on the analysis model used. 
• The benefit appeared stronger and longer-lasting in women. 
• Researchers estimated approximately:
• 1 Alzheimer case prevented per ~185 people receiving the high-dose vaccine. 
Important limitations:
• This was not a randomized controlled trial.
• People choosing high-dose vaccines may also:
• have better healthcare access,
• healthier lifestyles,
• better preventive care habits.
• Alzheimer disease develops over many years, but follow-up was only about 3 years. 
Possible mechanisms proposed:
• Better prevention of influenza infection and systemic inflammation.
• Modulation of immune activity and neuroinflammation.
• Stronger immune stimulation from the higher antigen dose. 
For older adults, the current practical interpretation is:
• Getting any flu vaccine is beneficial and important.
• If age ≥65 and available, the high-dose vaccine may provide somewhat better protection, both against influenza complications and possibly dementia risk.
• But it is still too early to say the high-dose vaccine definitively prevents Alzheimer disease. 
Reply all
Reply to author
Forward
0 new messages